Cipher Pharmaceuticals Inc. announced that Mr. Craig Mull has been named as Interim Chief Executive Officer of Cipher, replacing Robert Tessarolo. Mr. Mull is the Chair of the Board of Directors of Cipher and has extensive experience in the Canadian healthcare industry, including holding the position of COO with CML HealthCare, where he was responsible for the day-to-day operations.

The company provided earnings guidance for the second quarter ended June 30, 2019. For the quarter, the company expects total revenue in the range of $5.4 million to $5.6 million, compared with $6.95 million in second quarter 2018. The company expects earnings per share in the range of $0.04 to $0.05 compared with $0.07 in second quarter 2018.